DEDUCED RECKONING: Northwest Bio could be a perfect stocking stuffer
NWBO was one of three such drugs given this fast-track treatment in 2014. Six years later it seems a joke, but once they submit their drug application, they are assured a very fast review. That review time has been accelerated even more this year as the UK deals with Brexit and wants very much to remain at the forefront of drug approvals. That is why it beat the U.S. to approval of the Pfizer BioNTech vaccine now in distribution here and in the UK.
U.K. picks a controversial brain cancer vaccine as its first new 'innovative medicine'
the U.K. singled out a small U.S. biotech which is advancing a controversial new treatment for inoperable brain tumors for the country's new fast track.